down arrow

Marksans Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE750C01026
  • NSEID: MARKSANS
  • BSEID: 524404
INR
204.05
9.55 (4.91%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.67 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidated - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
45.32
45.32
40.93
40.93
40.93
40.93
Share Warrants & Outstandings
Total Reserve
2,019.74
1,699.85
1,068.24
845.56
595.08
501.55
Shareholder's Funds
2,065.05
1,745.16
1,202.27
886.50
636.01
542.48
Minority Interest
20.85
19.91
20.70
18.86
13.11
10.22
Long-Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
10.62
15.39
13.76
7.26
10.16
5.78
Other Long Term Liabilities
190.019
65.689
41.434
14.326
12.5204873
10
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
4.56
3.25
1.86
2.11
1.47
1.36
Total Non-Current Liabilities
205.20
84.33
57.05
23.70
24.15
17.14
Current Liabilities
Trade Payables
268.28
230.60
200.08
168.66
110.33
106.07
Other Current Liabilities
90.53
67.47
114.12
109.71
70.72
25.81
Short Term Borrowings
29.09
41.59
41.29
18.74
18.84
99.91
Short Term Provisions
1.96
1.33
0.72
1.85
28.86
0.84
Total Current Liabilities
389.85
340.99
356.22
298.97
228.75
232.62
Total Liabilities
2,680.95
2,190.39
1,636.24
1,228.02
902.03
802.46
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
1,193.49
828.26
726.26
551.92
552.34
506.26
Less: Accumulated Depreciation
417.55
341.95
297.96
242.56
260.52
236.54
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
775.94
486.31
428.31
309.36
291.81
269.73
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
5.38
7.25
0.69
5.60
0.00
0.00
Intangible assets under development
4.04
2.62
1.88
6.08
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
32.94
18.91
4.16
4.16
5.73
1.29
Other Non Current Assets
0.17
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
818.46
515.09
435.04
325.20
308.45
271.02
Current Assets Loans & Advances
Current Investments
26.99
0.54
0.43
0.26
0.00
0.00
Inventories
617.94
484.74
424.44
404.32
241.84
293.25
Sundry Debtors
453.18
416.85
394.78
271.95
243.35
176.60
Cash and Bank
673.58
714.96
349.26
212.18
93.73
33.54
Other Current Assets
35.90
24.65
27.41
13.13
11.06
27.83
Short Term Loans and Advances
54.90
33.56
4.87
0.98
3.61
0.23
Total Current Assets
1,862.49
1,675.30
1,201.20
902.82
593.59
531.44
Net Current Assets (Including Current Investments)
1,472.64
1,334.31
844.98
603.85
364.83
298.82
Total Current Assets Excluding Current Investments
1,835.50
1,674.76
1,200.77
902.56
593.59
531.44
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
2,680.95
2,190.39
1,636.24
1,228.02
902.03
802.46
Contingent Liabilities
0.00
1.45
1.45
19.78
48.17
30.40
Total Debt
29.09
41.59
41.29
18.74
18.84
99.91
Book Value per share (adjusted)
45.57
38.51
27.1
21.66
15.54
13.25
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2024 is -30.06% vs 0.73% in Mar 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2024 is 189.27% vs 58.56% in Mar 2023

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2024 is 58.31% vs 15.05% in Mar 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2024 is 11.17% vs 39.47% in Mar 2023

Compare Balance Sheet Results of Marksans Pharma
Markets Mojo
Figures in Rs cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
45.32
40.06
5.26
13.13%
Share Warrants & Outstandings
Total Reserve
2,019.74
9,299.78
-7,280.04
-78.28%
Shareholder's Funds
2,065.05
9,363.09
-7,298.04
-77.94%
Minority Interest
20.85
212.70
-191.85
-90.20%
Long-Term Borrowings
0.00
24.87
-24.87
-100.00%
Secured Loans
0.00
24.87
-24.87
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
10.62
8.67
1.95
22.49%
Other Long Term Liabilities
190.02
30.68
159.34
519.36%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
4.56
123.12
-118.56
-96.30%
Total Non-Current Liabilities
205.20
187.34
17.86
9.53%
Current Liabilities
Trade Payables
268.28
1,102.99
-834.71
-75.68%
Other Current Liabilities
90.53
456.26
-365.73
-80.16%
Short Term Borrowings
29.09
171.17
-142.08
-83.01%
Short Term Provisions
1.96
389.31
-387.35
-99.50%
Total Current Liabilities
389.85
2,119.73
-1,729.88
-81.61%
Total Liabilities
2,680.95
11,882.86
-9,201.91
-77.44%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1,193.49
5,775.71
-4,582.22
-79.34%
Less: Accumulated Depreciation
417.55
1,354.82
-937.27
-69.18%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
775.94
4,420.89
-3,644.95
-82.45%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
5.38
207.09
-201.71
-97.40%
Intangible assets under development
4.04
74.70
-70.66
-94.59%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
315.12
-315.12
-100.00%
Long Term Loans & Advances
32.94
163.97
-131.03
-79.91%
Other Non Current Assets
0.17
13.79
-13.62
-98.77%
Total Non-Current Assets
818.46
5,314.63
-4,496.17
-84.60%
Current Assets Loans & Advances
Current Investments
26.99
2,258.11
-2,231.12
-98.80%
Inventories
617.94
1,553.46
-935.52
-60.22%
Sundry Debtors
453.18
848.28
-395.10
-46.58%
Cash and Bank
673.58
1,197.97
-524.39
-43.77%
Other Current Assets
35.90
106.80
-70.90
-66.39%
Short Term Loans and Advances
54.90
610.77
-555.87
-91.01%
Total Current Assets
1,862.49
6,568.23
-4,705.74
-71.64%
Net Current Assets (Including Current Investments)
1,472.64
4,448.50
-2,975.86
-66.90%
Total Current Assets Excluding Current Investments
1,835.50
4,310.11
-2,474.61
-57.41%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
2,680.95
11,882.86
-9,201.91
-77.44%
Contingent Liabilities
0.00
116.23
-116.23
-100.00%
Total Debt
29.09
196.04
-166.95
-85.16%
Book Value per share (adjusted)
45.57
233.73
-188.16
-80.50%
Annual - Borrowings
Borrowings 29.09 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -30.06% vs 0.73% in Mar 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 190.02 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 189.27% vs 58.56% in Mar 2023

Annual - Fixed Assets
Fixed Assets 781.32 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 58.31% vs 15.05% in Mar 2023

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 1,862.49 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 11.17% vs 39.47% in Mar 2023